The content in this website was developed based on the information provided in the following references. Please note that the content in this website was […]

Canadian Abortion Provider Support – Communauté de pratique Canadienne sur l’avortement (CAPS-CPCA) is a web-based resource for clinicians and non-clinicians who are interested in providing […]

Canadian Abortion Providers Support – Commuanuté de pratique Canadienne sur l’avortement (CAPS-CPCA) is a virtual community of practice for clinicians and non-clinicians who are interested […]

Q: Is there an interaction between methadone and mifepristone? A: Bottom Line: Post-marketing surveillance of mifepristone use in numerous countries for the past 25 years has not raised […]

Q: Can Mifegymiso be used for the termination of multiple gestation (i.e. twin pregnancy)? What’s the evidence / success?A: Although one case- report revealed a […]

Q: Can I give Mifegymiso to a woman who is breastfeeding?A: The current available evidence suggests that for the current dose of Mifegymiso, breastfeeding does […]

Q: What will a person experience during the medication abortion with mifegymiso?A: A few hours after misoprostol administration, the person should expect bleeding heavier than a regular […]

Q: What topics should I cover in the initial pregnancy options counselling session with the person seeking abortion?A: These sessions typically include a discussion of: […]

Q: When was the mifepristone (RU-486) / misoprostol drug regimen first approved in Canada? In other countries?A: Mifegymiso was approved by Health Canada in July 2015[1]. It was first […]

A handbook for healthcare providers working with clients from diverse communities, 2019Action Canada for Sexual Health & RightsLink: [action-canada-handbook](C104-1) The Indigenous ally toolkit, 2018Montreal Urban Aboriginal […]